Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Gloria Pla Gonzalez"'
Autor:
Bert-Ram Sah, Michael Sommerauer, Linjing Mu, Gloria Pla Gonzalez, Susanne Geistlich, Valerie Treyer, Roger Schibli, Alfred Buck, Geoffrey Warnock, Simon M. Ametamey
Publikováno v:
EJNMMI Research, Vol 9, Iss 1, Pp 1-6 (2019)
Abstract Purpose (E)-3-(pyridin-2-ylethynyl)cyclohex-2-enone O-(3-(2-[18F]-fluoroethoxy)propyl) oxime ([18F]-PSS232) is a new PET tracer for imaging of metabotropic glutamate receptor subtype 5 (mGlu5), and has shown promising results in rodents and
Externí odkaz:
https://doaj.org/article/25e65f188ff04962924eeba6d01738bc
Autor:
Simon M. Ametamey, Susanne Geistlich, Stefanie-Dorothea Krämer, Geoffrey Warnock, Valerie Treyer, Linjing Mu, Gloria Pla Gonzalez, Roger Schibli, Alfred Buck, Michael Sommerauer
Publikováno v:
European Journal of Nuclear Medicine and Molecular Imaging. 45:1041-1051
Non-invasive imaging of metabotropic glutamate receptor 5 (mGlu5) in the brain using PET is of interest in e.g., anxiety, depression, and Parkinson’s disease. Widespread application of the most widely used mGlu5 tracer, [11C]ABP688, is limited by t
Autor:
Bert-Ram, Sah, Michael, Sommerauer, Linjing, Mu, Gloria Pla, Gonzalez, Susanne, Geistlich, Valerie, Treyer, Roger, Schibli, Alfred, Buck, Geoffrey, Warnock, Simon M, Ametamey
Publikováno v:
EJNMMI Research
Purpose (E)-3-(pyridin-2-ylethynyl)cyclohex-2-enone O-(3-(2-[18F]-fluoroethoxy)propyl) oxime ([18F]-PSS232) is a new PET tracer for imaging of metabotropic glutamate receptor subtype 5 (mGlu5), and has shown promising results in rodents and humans. T
Autor:
Geoffrey, Warnock, Michael, Sommerauer, Linjing, Mu, Gloria, Pla Gonzalez, Susanne, Geistlich, Valerie, Treyer, Roger, Schibli, Alfred, Buck, Stefanie D, Krämer, Simon M, Ametamey
Publikováno v:
European journal of nuclear medicine and molecular imaging. 45(6)
Non-invasive imaging of metabotropic glutamate receptor 5 (mGlu[At 90 min post-injection, 59.2 ± 11.1% of total radioactivity in plasma corresponded to intact tracer. The regional first pass extraction fraction of [Brain uptake of [